AI agents for healthcare: diagnostics, insurance claims, and the regulatory minefield

Healthcare is where the stakes of getting AI wrong are measured in something other than money. A misrouted delivery costs you a refund. A misclassified insurance claim costs someone their coverage. A missed diagnostic indicator costs someone something worse. That context shapes everything I’m going to say here.

I’m genuinely interested in what AI agents can do in healthcare. I’m also honest about what they can’t do, and what should stay firmly in human hands. That combination of interest and honesty is rarer than it should be in AI coverage, so let me try to apply it here.

Diagnostic assistance: what the research projects actually show

The HIA (Health Intelligent Agent) project and ahmadvh’s AI-Agents-for-Medical-Diagnostics repository on GitHub show what serious AI-assisted diagnostics research currently looks like at the open-source level. These aren’t consumer products. They’re experimental frameworks for understanding how multi-agent AI systems can support clinical decision-making – which is a very different thing.

The architectural pattern is consistent across these projects: a set of specialised agents, each focused on a specific diagnostic domain or data type, co-ordinated by an orchestrating agent that synthesises their outputs. One agent processes symptom descriptions and medical history. Another reviews lab values against reference ranges. Another checks for drug interactions or contraindications. The orchestrator combines these into a differential diagnosis or risk flag for a clinician to review.

That word – review – matters enormously. Every serious implementation of AI in diagnostics treats the AI output as decision support, not decision-making. The agent surfaces patterns, flags anomalies, draws attention to things that warrant closer examination. The clinician evaluates the flag, applies their clinical judgement, and makes the actual assessment. These roles aren’t interchangeable.

This distinction matters because it determines the regulatory category a system falls into. An AI that assists a clinician is a fundamentally different legal and regulatory question from an AI that makes autonomous clinical decisions. Most healthcare AI projects that have survived regulatory scrutiny sit firmly in the support category – and that’s not a limitation, it’s a design choice.

Where diagnostic AI shows genuine, measurable value today: pattern recognition at scale across large patient cohorts (flagging high-risk patients who need follow-up before they deteriorate), processing imaging data faster than a single radiologist working through a queue, and cross-referencing symptom combinations against known rare condition presentations that a generalist might not recall immediately. Assistance functions, not replacement functions.

Insurance claims automation: the clearest near-term application

Health insurance claims processing is, bluntly, a bureaucratic nightmare that consumes enormous time and generates significant errors on both sides. Claimants submit incomplete or incorrectly coded claims. Insurers reject valid claims on technicalities. Appeals processes are slow and opaque. Everyone loses time and trust.

This is exactly the kind of structured, rule-heavy, document-intensive workflow that AI agents handle well. Projects like MediSuite-Ai-Agent demonstrate the architecture: agents that read claim submissions, verify coding against current billing standards (ICD-10, CPT codes), check eligibility criteria against policy terms, identify missing documentation, and flag discrepancies before human reviewers even see them.

The value here is throughput and consistency. A human claims processor reviewing fifty claims a day will inevitably introduce variance – different interpretations of edge cases, fatigue affecting attention to detail, unfamiliarity with recently updated billing codes. An agent applying the same rules to the same inputs produces consistent outputs, every time. The human reviewer then focuses on exceptions and genuine judgement calls.

For insurers: faster processing, fewer erroneous denials, better audit trails. For healthcare providers: faster payment and fewer rejections requiring manual resubmission. The ROI case is clear, and the regulatory risk is manageable because the agent is processing paperwork, not making clinical decisions.

If you’re a healthtech startup working with healthcare providers, a claims pre-processing agent that validates submissions before they leave the practice can meaningfully reduce rejection rates. The data inputs are structured. The rules are documented. The feedback loop – accepted versus rejected claims – is clear. The implementation challenge here is lower than most people assume.

Patient data monitoring: continuous attention at machine scale

Remote patient monitoring is one of the areas where the fundamental capability advantage of AI agents – running continuously without fatigue – maps most directly to clinical value. A patient monitoring agent watching continuous glucose readings, cardiac telemetry, or post-surgical vital signs can flag deterioration patterns hours before they become emergencies.

The clinical reality is that nurses and monitoring staff can’t watch every patient continuously. They triage attention, because they have to. An AI monitoring agent doesn’t triage. It watches everything simultaneously and alerts only when a threshold is breached or a pattern emerges that warrants human attention. This isn’t replacing clinical judgement – it’s ensuring that clinical judgement gets directed at the right patients at the right time.

The data infrastructure required here is significant. Real-time monitoring means real-time data ingestion, low-latency processing, and alert delivery that integrates with clinical workflows – not just emails or text messages. The FHIR standard (Fast Healthcare Interoperability Resources) is worth understanding if you’re building in this space. It’s the dominant standard for healthcare data exchange, and any serious integration will need to speak it.

The regulatory dimension: not optional, not later

Healthcare AI sits in a specific regulatory category you can’t ignore until you’re ready to ship. In the UK, the MHRA (Medicines and Healthcare products Regulatory Agency) regulates software as a medical device. In the EU, the MDR applies. In the US, it’s the FDA’s Software as a Medical Device framework.

Whether your AI system requires regulatory clearance depends primarily on its intended purpose and the claims you make about it. If your system influences clinical decisions, it’s likely a medical device under these frameworks. If it processes administrative data without touching clinical pathways, it probably isn’t. The line matters enormously and you should get legal advice specific to your jurisdiction and use case before deploying anything in a clinical setting.

This isn’t a reason to avoid healthcare AI. It’s a reason to engage with the regulatory question early. Projects that build with regulatory requirements in mind from the start – audit trails, version control, performance validation, clinical validation studies – are in a fundamentally different position from projects that deploy fast and face these questions later. The latter rarely ends well.

I’ve written generally about the risks of autonomous AI in business, and healthcare is where those risks are sharpest. The same principles apply with higher stakes: define human oversight checkpoints clearly, build the audit trail in from the start, never give autonomous decision authority on anything with patient safety implications.

Liability: who’s responsible when the agent is wrong?

This is the question nobody wants to answer directly, but it’s the most important one for any founder considering healthcare AI. Current legal frameworks are genuinely unclear on AI liability in medical contexts. The law is catching up to the technology, and in the meantime, liability typically flows to the entity that deployed the system and the clinician who acted on its output.

This has practical implications for how you architect things. Decisions made by AI agents need clear documentation. Clinicians acting on AI recommendations need to be able to see the reasoning, not just the conclusion. Recommendations need to include confidence levels and known limitations. Anything that could be misread as a definitive clinical conclusion should be explicitly scoped as supporting information only.

Insurance matters too. Clinical AI deployments require specific professional indemnity and product liability coverage. Standard tech company insurance doesn’t cover clinical AI liability adequately. This is another conversation to have early, not after you’ve deployed.

What founders can actually build today

If you’re a founder looking at healthcare AI, here’s an honest assessment of the viable near-term opportunities for a small team:

• Claims pre-processing and validation: High value, manageable regulatory risk, clear ROI. Build the agent that catches submission errors before claims go to insurers.
• Appointment scheduling and patient communication: Lower regulatory complexity, genuine efficiency gains. Agents that handle booking, reminders, and routine patient queries without clinical content.
• Clinical documentation support: Agents that help clinicians document consultations faster — transcribing, structuring notes, suggesting ICD codes for the clinician to confirm. Decision support, clearly scoped.
• Data quality and monitoring alerts: For healthcare providers with existing monitoring infrastructure, agents that improve alert accuracy and reduce false positive fatigue.

What to avoid at the early stage: autonomous diagnostic conclusions, any system that operates without clear clinician review checkpoints, and anything that touches prescription or treatment decisions without extensive clinical validation and regulatory clearance.

Where human judgement is non-negotiable

There’s a category of clinical judgement that AI cannot and should not be designed to replace – not because the technology will never improve, but because the human relationship and accountability in medical care isn’t purely an information-processing problem.

Communicating a serious diagnosis requires human presence. End-of-life care decisions require human wisdom. Navigating a patient’s emotional state during a difficult consultation requires empathy that can’t be automated. The clinical relationship is partly about trust built over time, and that trust depends on a human being responsible and accountable for the care being given.

AI agents in healthcare that are built with clarity about this boundary – supporting clinicians on the information-processing and administrative sides, explicitly not replacing the human-to-human clinical relationship – are the ones that will earn trust, navigate regulation, and deliver lasting value. The ones that blur this boundary are the ones that generate the cautionary tales.

Build in healthcare if you see a genuine problem you can solve. Just be honest with yourself about which problems are yours to solve and which aren’t.

AI agents for healthcare: diagnostics, insurance claims, and the regulatory minefield